Clinical trials for HER-2 positive breast cancer

 

Trial name

 

Title of clinical trial

 

Hyperlink

 

ADD-ASPIRIN

 

A study assessing the effects of aspirin on disease recurrence and survival after primary therapy.
Open to men & women.

 

Clinical Trials Information

 

PHERgain

 

Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
Open to men & women.

 

Clinical Trials Information